Kuopio
Finland
46
2025-05-22
The entities that hold a legal rights for patent applications filed by inventor YLA-HERTTUALA Seppo:
Seppo YLA-HERTTUALA from Kuopio, FI has applied for patents for these inventions. The list has both pending applications and granted patents:
GENE THERAPY VECTOR CONTAMINATION ASSAY
#2 | 2023-07-27ANTI-ANGIOGENIC GENE THERAPY WITH SOLUBLE VEGF RECEPTORS -1, -2 AND -3 TOGETHER WITH PACLITAXEL PROLONGS SURVIVAL OF MICE WITH HUMAN OVARIAN CARCINOMA
#3 | 2023-07-20COMPOSITIONS AND METHODS FOR TREATING CANCER
#4 | 2022-11-17Method of manufacturing a recombinant polypeptide
#5 | 2020-11-12Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity
#6 | 2020-07-16Method to Curtail the Progression of Non-Muscle Invasive Bladder Cancer To Muscle-Invasive Cancer
#7 | 2020-04-02Transgene-Cytotoxic Combination Therapy
#8 | 2020-03-05Nucleic acid application primers
#9 | 2019-09-26Gene therapy vector contamination assay
#10 | 2019-09-12Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion Time
#11 | 2019-09-12Anti-Angiogenic Gene Therapy Kit
#12 | 2019-07-18Aseptic bioreactor sampling system
#13 | 2019-01-31Fixed-bed bioreactor with constant-flow pump / tubing system
#14 | 2017-12-07Combination Therapy For Cancer
#15 | 2017-02-23Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion Time
#16 | 2017-01-19Production of Lentiviral Vectors
#17 | 2016-04-07Production of Vectors for Non-Dividing Host Cells
#18 | 2016-03-03Treatment of Operable High-Grade Glioma With Sitimagene Ceradenovec Gene Therapy and Ganciclovir
#19 | 2014-02-27Anti-Angiogenic Gene Therapy With Soluble VEGF Receptors -1, -2 and -3 Together With Paclitaxel Prolongs Survival Of Mice With Human Ovarian Carcinoma
#20 | 2014-01-16Transfection of Mesothelium Body Cavity Lining with Gene Agents Followed by Chemotharapy to Treat Cancer of Organs in the Body Cavity
#21 | 2014-01-16Transfection of Mesothelium Body Cavity Lining with Gene Agents Followed by Chemotharapy to Treat Cancer of Organs in the Body Cavity
#22 | 2013-12-12Combination Therapy for Cancer
#23 | 2013-11-21Combination Therapy for Cancer
#24 | 2013-11-07Combination Therapy for Cancer
#25 | 2012-12-06Therapeutic Use of Growth Factor, and Delivery Device, Especially for the Treatment of Intimal Hyperplasia
#26 | 2011-06-16VEGF-D mutants and their use
#27 | 2011-03-03Non-Aggregating Virus Formulation
#28 | 2010-09-02Method for Incorporating Proteins Into Lentivirus Vectors
#29 | 2010-01-07Production of Lentiviral Vectors
#30 | 2009-07-09Engineered Baculoviruses and Their Use
#31 | 2009-02-19Avidin-Pseudotyped Viral Vectors and Their Use
#32 | 2009-01-08Biotin-binding receptor molecules
#33 | 2009-01-08INTEGRASE FUSION PROTEINS AND THEIR USE WITH INTEGRATING GENE THERAPY
#34 | 2008-12-11Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
#35 | 2008-11-13Baculovirus-Based Gene Libraries
#36 | 2008-11-13Pseudotyped Baculovirus and its Use
#37 | 2008-10-23Peptides and their use in assays for cardiovascular disease
#38 | 2008-06-19Use of VEGF-C or VEGF-D in Reconstructive Surgery
#39 | 2008-01-22Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
#40 | 2007-09-27Expression Cassette
#41 | 2007-04-24Nucleic acids encoding biotin-binding receptors
#42 | 2006-11-02Avidin-pseudotyped viral vectors and their use
#43 | 2006-05-04Periadventitial delivery device
#44 | 2005-11-17Use of VEGF-D gene to prevent restenosis
#45 | 2005-10-25Use of VEGF-C to prevent restenosis
#46 | 2005-09-15Engineered baculoviruses and their use
520175 ⎘